Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 2 (A) Mean left ventricular developed pressure (LVDP) during reperfusion of hearts treated with cytoskeletal specific immunoliposomes (CSIL) at 5 min of ischemia (CSIL 5'), immunoglobulin G liposomes (IgG-L) at 5 min of ischemia (IgG-L 5'), phosphate buffered saline (PBS), or sham instrumentation. (B) Mean LVDP during reperfusion of hearts treated with CSIL or IgG-L at 10 min of ischemia (CSIL 10' and IgG-L 10'), PBS, or sham. (C) Mean LVDP during reperfusion of hearts treated with CSIL or IgG-L at 20 min of ischemia (CSIL 20' and IgG-L 20'), PBS, or sham. (A through C) Sham = solid circles; CSIL = squares; IgG-L = triangles; PBS = open circles. (D) Mean LVDP assessed at 20 to 30 min of reperfusion (plateau phase) in hearts treated with CSIL, IgG-L, or PBS.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement